Pediatric Pneumococcal Disease Research Grant 2026

Deadline: Jun 01, 2026

other

partially funded

Saudi Arabia

To Apply

Please visit the application link below to apply.

Opportunity Overview

📝 About Pfizer Pediatric Pneumococcal Disease Research Grant

Pfizer’s research grant program supports projects addressing critical gaps in understanding pneumococcal disease epidemiology in children under five in Saudi Arabia. The program encourages robust study designs, such as prospective or bidirectional cohort studies, to produce actionable epidemiological data that informs public health strategies.

💰 Benefits of the Grant

Maximum funding per project: $400,000 USD (higher-cost projects considered on a case-by-case basis).

✅ Eligibility Criteria

To qualify for the Pfizer Pediatric Pneumococcal Disease Research Grant, applicants must meet the following requirements:

The institution and Principal Investigator (PI) must be based in Saudi Arabia.
Only organizations are eligible to receive grants. Multicenter collaboration is encouraged.
Individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society) are not eligible to receive grants.
If the project involves multiple departments within an institution and/or between different institutions/organizations/associations:
- All institutions must have a relevant role.
- The requesting organization must have a key role in the project.
The PI must have one of the following qualifications:
- Medical or postdoctoral degree (MD, PhD, or equivalent).
- Advanced nursing degree (BSN with a MS/PhD).
- Degree in Pharmacy.
The applicant must be the PI or an authorized designee of such individual (e.g., PI’s research coordinator).
The PI must be an employee or contractor of the requesting organization.
The requesting organization must be legally able to receive award funding directly from Pfizer International LLC. Applicants are strongly recommended to confirm this with their organization or institution prior to submitting an application.
- Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer International LLC may be subject to rescission.

📅 Application Date and Process

Application Deadline: 01 June, 2026.
To apply, visit the application website.

📄 Opportunity Application

For detailed information about the Pfizer Pediatric Pneumococcal Disease Research Grant, refer to the official documentation provided by Pfizer.

Sponsor: Pfizer

This grant offers a unique opportunity to contribute to public health strategies by addressing critical gaps in pediatric pneumococcal disease research. Ensure you meet all eligibility criteria and submit your application before the deadline!

Benefits

Maximum funding per project: $400,000 USD (higher-cost projects considered case-by-case)

Reading papers feels like a chore?

Skip the struggle of dense PDFs. Our multilingual audio briefs turn complex research into clear, engaging summaries, perfect for learning while walking, commuting, or cooking.